Semaglutide vs Tesamorelin.
Quick Verdict
Semaglutide is a glp-1 agonist primarily researched for fat loss, appetite control, cardiovascular benefits, while Tesamorelin is a ghrh analog studied for visceral fat reduction, body recomposition.
Side-by-Side Analysis
| Dimension | Semaglutide | Tesamorelin |
|---|---|---|
| Category | GLP-1 Agonist | GHRH Analog |
| Mechanism | GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection. | Stimulates GH for fat metabolism. |
| Half-Life | ~7 days | ~26 minutes |
| Route | SubQ | SubQ |
| Typical Dose | 250–250 mcg | 1000–1000 mcg |
| Frequency | 1x/wk | 7x/week |
| Evidence Level | Very Strong | Very Strong |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Approved | Approved |
| Lowest Price | $47.99 / 5mg via Amino Club | $69.99 / 10mg via Amino Club |
| Per-mg Cost | $9.60/mg | $7.00/mg |
Mechanism of Action Comparison
How Semaglutide Works
Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes (Ozempic) and obesity (Wegovy), reducing appetite and improving blood sugar control.
GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection.
How Tesamorelin Works
Tesamorelin Tesamorelin is the only FDA-approved growth-hormone-releasing peptide (Egrifta) indicated specifically for reducing visceral abdominal fat in HIV-associated lipodystrophy.
Stimulates GH for fat metabolism. Binds to GHRH receptors on the pituitary gland to stimulate natural growth hormone production, specifically targeting visceral adipose tissue.
Key Mechanistic Difference
Semaglutide operates as a glp-1 agonist, while Tesamorelin functions as a ghrh analog — these are fundamentally different pharmacological approaches. Semaglutide has a significantly longer half-life (~7 days) compared to Tesamorelin (~26 minutes), which impacts dosing frequency and sustained activity.
Research Evidence
Semaglutide
20 studies- STEP 1: Semaglutide 2.4 mg for weight managementWilding et al. (NEJM): Landmark STEP 1 trial semaglutide 2.4mg achieved 14.9% mean weight loss vs 2.4% placebo at 68 w…Very Strong
- SELECT trial: semaglutide reduces cardiovascular events by 20%Lincoff et al. (NEJM): SELECT trial shows semaglutide 2.4mg reduces major adverse cardiovascular events by 20% in overwe…Very Strong
- STEP program overview: pooled Phase 3 weight loss dataComprehensive analysis across STEP trials showing 14.9-17.4% weight loss, improved cardiometabolic risk factors, blood p…Very Strong
Tesamorelin
20 studies- Tesamorelin visceral fat reduction (FDA trial)Falutz et al. (JAMA): Randomized, double-blind, placebo-controlled Phase 3 trial showing 15.2% reduction in visceral adi…Very Strong
- Tesamorelin 52-week extension study sustained VAT reductionFalutz et al. (J. Clin. Endocrinol. Metab.): 52-week data confirming sustained 18% visceral fat reduction with continuou…Strong
- Tesamorelin reduces liver fat in HIV lipodystrophyStanley et al. (Ann. Intern. Med.): RCT demonstrating tesamorelin reduces hepatic fat content in HIV-infected patients w…Strong
Vendor Pricing
· Affiliate links · Prices verified 2026Semaglutide
2 vendorsAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take Semaglutide and Tesamorelin together?▼
No direct interaction data is available for this specific pair. They target different receptor systems, suggesting they could potentially be combined, but no published protocol validates this combination.
Which has more research evidence — Semaglutide or Tesamorelin?▼
Semaglutide has 20 indexed studies (highest evidence: Very Strong). Tesamorelin has 20 indexed studies (highest evidence: Very Strong). Both have comparable research coverage.
What is the price difference between Semaglutide and Tesamorelin?▼
At current verified vendor prices, Tesamorelin starts at $7.00/mg while Semaglutide starts at $9.60/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for fat loss — Semaglutide or Tesamorelin?▼
Both are researched for fat loss. Semaglutide addresses this via fat loss, appetite control, cardiovascular benefits. Tesamorelin approaches it through visceral fat reduction, body recomposition. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Related Comparisons
Deep Dive Profiles
Shared Research Goals
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.